Global Hyperthyroidism Medications Supply, Demand and Key Producers, 2024-2030

Description

The global Hyperthyroidism Medications market size is expected to reach $ 699.6 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.

This report studies the global Hyperthyroidism Medications production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hyperthyroidism Medications, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperthyroidism Medications that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hyperthyroidism Medications total production and demand, 2019-2030, (K Units)
Global Hyperthyroidism Medications total production value, 2019-2030, (USD Million)
Global Hyperthyroidism Medications production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Hyperthyroidism Medications consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Hyperthyroidism Medications domestic production, consumption, key domestic manufacturers and share
Global Hyperthyroidism Medications production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Hyperthyroidism Medications production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Hyperthyroidism Medications production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Hyperthyroidism Medications market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical and Zibo Wankang Pharmaceutical Chemical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperthyroidism Medications market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hyperthyroidism Medications Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hyperthyroidism Medications Market, Segmentation by Type
    Methimazole
    Propylthiouracil
    Other

Global Hyperthyroidism Medications Market, Segmentation by Application
    Hospital
    Clinic
    Other

Companies Profiled:
    Merck
    Herbrand PharmaChemicals
    Shanghai Zhaohui Pharmaceutical
    Beijing Yanjing Pharmaceutical
    Jinghua Pharmaceutical Group
    Guangzhou Kanghe Pharmaceutical
    Zigong Honghe Pharmaceutical
    Guangdong Huanan Pharmaceutical
    Zibo Wankang Pharmaceutical Chemical
    Qilu Pharmaceutical

Key Questions Answered
1. How big is the global Hyperthyroidism Medications market?
2. What is the demand of the global Hyperthyroidism Medications market?
3. What is the year over year growth of the global Hyperthyroidism Medications market?
4. What is the production and production value of the global Hyperthyroidism Medications market?
5. Who are the key producers in the global Hyperthyroidism Medications market?

Table of Contents

1 Supply Summary
    1.1 Hyperthyroidism Medications Introduction
    1.2 World Hyperthyroidism Medications Supply & Forecast
        1.2.1 World Hyperthyroidism Medications Production Value (2019 & 2023 & 2030)
        1.2.2 World Hyperthyroidism Medications Production (2019-2030)
        1.2.3 World Hyperthyroidism Medications Pricing Trends (2019-2030)
    1.3 World Hyperthyroidism Medications Production by Region (Based on Production Site)
        1.3.1 World Hyperthyroidism Medications Production Value by Region (2019-2030)
        1.3.2 World Hyperthyroidism Medications Production by Region (2019-2030)
        1.3.3 World Hyperthyroidism Medications Average Price by Region (2019-2030)
        1.3.4 North America Hyperthyroidism Medications Production (2019-2030)
        1.3.5 Europe Hyperthyroidism Medications Production (2019-2030)
        1.3.6 China Hyperthyroidism Medications Production (2019-2030)
        1.3.7 Japan Hyperthyroidism Medications Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hyperthyroidism Medications Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hyperthyroidism Medications Major Market Trends

2 Demand Summary
    2.1 World Hyperthyroidism Medications Demand (2019-2030)
    2.2 World Hyperthyroidism Medications Consumption by Region
        2.2.1 World Hyperthyroidism Medications Consumption by Region (2019-2024)
        2.2.2 World Hyperthyroidism Medications Consumption Forecast by Region (2025-2030)
    2.3 United States Hyperthyroidism Medications Consumption (2019-2030)
    2.4 China Hyperthyroidism Medications Consumption (2019-2030)
    2.5 Europe Hyperthyroidism Medications Consumption (2019-2030)
    2.6 Japan Hyperthyroidism Medications Consumption (2019-2030)
    2.7 South Korea Hyperthyroidism Medications Consumption (2019-2030)
    2.8 ASEAN Hyperthyroidism Medications Consumption (2019-2030)
    2.9 India Hyperthyroidism Medications Consumption (2019-2030)

3 World Hyperthyroidism Medications Manufacturers Competitive Analysis
    3.1 World Hyperthyroidism Medications Production Value by Manufacturer (2019-2024)
    3.2 World Hyperthyroidism Medications Production by Manufacturer (2019-2024)
    3.3 World Hyperthyroidism Medications Average Price by Manufacturer (2019-2024)
    3.4 Hyperthyroidism Medications Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Hyperthyroidism Medications Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Hyperthyroidism Medications in 2023
        3.5.3 Global Concentration Ratios (CR8) for Hyperthyroidism Medications in 2023
    3.6 Hyperthyroidism Medications Market: Overall Company Footprint Analysis
        3.6.1 Hyperthyroidism Medications Market: Region Footprint
        3.6.2 Hyperthyroidism Medications Market: Company Product Type Footprint
        3.6.3 Hyperthyroidism Medications Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Hyperthyroidism Medications Production Value Comparison
        4.1.1 United States VS China: Hyperthyroidism Medications Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Hyperthyroidism Medications Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Hyperthyroidism Medications Production Comparison
        4.2.1 United States VS China: Hyperthyroidism Medications Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hyperthyroidism Medications Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Hyperthyroidism Medications Consumption Comparison
        4.3.1 United States VS China: Hyperthyroidism Medications Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Hyperthyroidism Medications Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Hyperthyroidism Medications Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Hyperthyroidism Medications Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Hyperthyroidism Medications Production (2019-2024)
    4.5 China Based Hyperthyroidism Medications Manufacturers and Market Share
        4.5.1 China Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Hyperthyroidism Medications Production Value (2019-2024)
        4.5.3 China Based Manufacturers Hyperthyroidism Medications Production (2019-2024)
    4.6 Rest of World Based Hyperthyroidism Medications Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Hyperthyroidism Medications Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Hyperthyroidism Medications Production (2019-2024)

5 Market Analysis by Type
    5.1 World Hyperthyroidism Medications Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Methimazole
        5.2.2 Propylthiouracil
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Hyperthyroidism Medications Production by Type (2019-2030)
        5.3.2 World Hyperthyroidism Medications Production Value by Type (2019-2030)
        5.3.3 World Hyperthyroidism Medications Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Hyperthyroidism Medications Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Hyperthyroidism Medications Production by Application (2019-2030)
        6.3.2 World Hyperthyroidism Medications Production Value by Application (2019-2030)
        6.3.3 World Hyperthyroidism Medications Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck Hyperthyroidism Medications Product and Services
        7.1.4 Merck Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Herbrand PharmaChemicals
        7.2.1 Herbrand PharmaChemicals Details
        7.2.2 Herbrand PharmaChemicals Major Business
        7.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
        7.2.4 Herbrand PharmaChemicals Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Herbrand PharmaChemicals Recent Developments/Updates
        7.2.6 Herbrand PharmaChemicals Competitive Strengths & Weaknesses
    7.3 Shanghai Zhaohui Pharmaceutical
        7.3.1 Shanghai Zhaohui Pharmaceutical Details
        7.3.2 Shanghai Zhaohui Pharmaceutical Major Business
        7.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
        7.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
        7.3.6 Shanghai Zhaohui Pharmaceutical Competitive Strengths & Weaknesses
    7.4 Beijing Yanjing Pharmaceutical
        7.4.1 Beijing Yanjing Pharmaceutical Details
        7.4.2 Beijing Yanjing Pharmaceutical Major Business
        7.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
        7.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
        7.4.6 Beijing Yanjing Pharmaceutical Competitive Strengths & Weaknesses
    7.5 Jinghua Pharmaceutical Group
        7.5.1 Jinghua Pharmaceutical Group Details
        7.5.2 Jinghua Pharmaceutical Group Major Business
        7.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
        7.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Jinghua Pharmaceutical Group Recent Developments/Updates
        7.5.6 Jinghua Pharmaceutical Group Competitive Strengths & Weaknesses
    7.6 Guangzhou Kanghe Pharmaceutical
        7.6.1 Guangzhou Kanghe Pharmaceutical Details
        7.6.2 Guangzhou Kanghe Pharmaceutical Major Business
        7.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
        7.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
        7.6.6 Guangzhou Kanghe Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Zigong Honghe Pharmaceutical
        7.7.1 Zigong Honghe Pharmaceutical Details
        7.7.2 Zigong Honghe Pharmaceutical Major Business
        7.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
        7.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
        7.7.6 Zigong Honghe Pharmaceutical Competitive Strengths & Weaknesses
    7.8 Guangdong Huanan Pharmaceutical
        7.8.1 Guangdong Huanan Pharmaceutical Details
        7.8.2 Guangdong Huanan Pharmaceutical Major Business
        7.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
        7.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
        7.8.6 Guangdong Huanan Pharmaceutical Competitive Strengths & Weaknesses
    7.9 Zibo Wankang Pharmaceutical Chemical
        7.9.1 Zibo Wankang Pharmaceutical Chemical Details
        7.9.2 Zibo Wankang Pharmaceutical Chemical Major Business
        7.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
        7.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
        7.9.6 Zibo Wankang Pharmaceutical Chemical Competitive Strengths & Weaknesses
    7.10 Qilu Pharmaceutical
        7.10.1 Qilu Pharmaceutical Details
        7.10.2 Qilu Pharmaceutical Major Business
        7.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
        7.10.4 Qilu Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Qilu Pharmaceutical Recent Developments/Updates
        7.10.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hyperthyroidism Medications Industry Chain
    8.2 Hyperthyroidism Medications Upstream Analysis
        8.2.1 Hyperthyroidism Medications Core Raw Materials
        8.2.2 Main Manufacturers of Hyperthyroidism Medications Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Hyperthyroidism Medications Production Mode
    8.6 Hyperthyroidism Medications Procurement Model
    8.7 Hyperthyroidism Medications Industry Sales Model and Sales Channels
        8.7.1 Hyperthyroidism Medications Sales Model
        8.7.2 Hyperthyroidism Medications Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hyperthyroidism Medications Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Hyperthyroidism Medications Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Hyperthyroidism Medications Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Hyperthyroidism Medications Production Value Market Share by Region (2019-2024)
    Table 5. World Hyperthyroidism Medications Production Value Market Share by Region (2025-2030)
    Table 6. World Hyperthyroidism Medications Production by Region (2019-2024) & (K Units)
    Table 7. World Hyperthyroidism Medications Production by Region (2025-2030) & (K Units)
    Table 8. World Hyperthyroidism Medications Production Market Share by Region (2019-2024)
    Table 9. World Hyperthyroidism Medications Production Market Share by Region (2025-2030)
    Table 10. World Hyperthyroidism Medications Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Hyperthyroidism Medications Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Hyperthyroidism Medications Major Market Trends
    Table 13. World Hyperthyroidism Medications Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Hyperthyroidism Medications Consumption by Region (2019-2024) & (K Units)
    Table 15. World Hyperthyroidism Medications Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Hyperthyroidism Medications Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Hyperthyroidism Medications Producers in 2023
    Table 18. World Hyperthyroidism Medications Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Hyperthyroidism Medications Producers in 2023
    Table 20. World Hyperthyroidism Medications Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Hyperthyroidism Medications Company Evaluation Quadrant
    Table 22. World Hyperthyroidism Medications Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Hyperthyroidism Medications Production Site of Key Manufacturer
    Table 24. Hyperthyroidism Medications Market: Company Product Type Footprint
    Table 25. Hyperthyroidism Medications Market: Company Product Application Footprint
    Table 26. Hyperthyroidism Medications Competitive Factors
    Table 27. Hyperthyroidism Medications New Entrant and Capacity Expansion Plans
    Table 28. Hyperthyroidism Medications Mergers & Acquisitions Activity
    Table 29. United States VS China Hyperthyroidism Medications Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Hyperthyroidism Medications Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Hyperthyroidism Medications Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Hyperthyroidism Medications Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Hyperthyroidism Medications Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Hyperthyroidism Medications Production Market Share (2019-2024)
    Table 37. China Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Hyperthyroidism Medications Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Hyperthyroidism Medications Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Hyperthyroidism Medications Production Market Share (2019-2024)
    Table 42. Rest of World Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Hyperthyroidism Medications Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Hyperthyroidism Medications Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Hyperthyroidism Medications Production Market Share (2019-2024)
    Table 47. World Hyperthyroidism Medications Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Hyperthyroidism Medications Production by Type (2019-2024) & (K Units)
    Table 49. World Hyperthyroidism Medications Production by Type (2025-2030) & (K Units)
    Table 50. World Hyperthyroidism Medications Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Hyperthyroidism Medications Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Hyperthyroidism Medications Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Hyperthyroidism Medications Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Hyperthyroidism Medications Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Hyperthyroidism Medications Production by Application (2019-2024) & (K Units)
    Table 56. World Hyperthyroidism Medications Production by Application (2025-2030) & (K Units)
    Table 57. World Hyperthyroidism Medications Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Hyperthyroidism Medications Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Hyperthyroidism Medications Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Hyperthyroidism Medications Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Merck Basic Information, Manufacturing Base and Competitors
    Table 62. Merck Major Business
    Table 63. Merck Hyperthyroidism Medications Product and Services
    Table 64. Merck Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Merck Recent Developments/Updates
    Table 66. Merck Competitive Strengths & Weaknesses
    Table 67. Herbrand PharmaChemicals Basic Information, Manufacturing Base and Competitors
    Table 68. Herbrand PharmaChemicals Major Business
    Table 69. Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
    Table 70. Herbrand PharmaChemicals Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Herbrand PharmaChemicals Recent Developments/Updates
    Table 72. Herbrand PharmaChemicals Competitive Strengths & Weaknesses
    Table 73. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 74. Shanghai Zhaohui Pharmaceutical Major Business
    Table 75. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
    Table 76. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
    Table 78. Shanghai Zhaohui Pharmaceutical Competitive Strengths & Weaknesses
    Table 79. Beijing Yanjing Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 80. Beijing Yanjing Pharmaceutical Major Business
    Table 81. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
    Table 82. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Beijing Yanjing Pharmaceutical Recent Developments/Updates
    Table 84. Beijing Yanjing Pharmaceutical Competitive Strengths & Weaknesses
    Table 85. Jinghua Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 86. Jinghua Pharmaceutical Group Major Business
    Table 87. Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
    Table 88. Jinghua Pharmaceutical Group Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Jinghua Pharmaceutical Group Recent Developments/Updates
    Table 90. Jinghua Pharmaceutical Group Competitive Strengths & Weaknesses
    Table 91. Guangzhou Kanghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 92. Guangzhou Kanghe Pharmaceutical Major Business
    Table 93. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
    Table 94. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
    Table 96. Guangzhou Kanghe Pharmaceutical Competitive Strengths & Weaknesses
    Table 97. Zigong Honghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 98. Zigong Honghe Pharmaceutical Major Business
    Table 99. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
    Table 100. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Zigong Honghe Pharmaceutical Recent Developments/Updates
    Table 102. Zigong Honghe Pharmaceutical Competitive Strengths & Weaknesses
    Table 103. Guangdong Huanan Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 104. Guangdong Huanan Pharmaceutical Major Business
    Table 105. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
    Table 106. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Guangdong Huanan Pharmaceutical Recent Developments/Updates
    Table 108. Guangdong Huanan Pharmaceutical Competitive Strengths & Weaknesses
    Table 109. Zibo Wankang Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
    Table 110. Zibo Wankang Pharmaceutical Chemical Major Business
    Table 111. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
    Table 112. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
    Table 114. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 115. Qilu Pharmaceutical Major Business
    Table 116. Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
    Table 117. Qilu Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 118. Global Key Players of Hyperthyroidism Medications Upstream (Raw Materials)
    Table 119. Hyperthyroidism Medications Typical Customers
    Table 120. Hyperthyroidism Medications Typical Distributors
List of Figure
    Figure 1. Hyperthyroidism Medications Picture
    Figure 2. World Hyperthyroidism Medications Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Hyperthyroidism Medications Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Hyperthyroidism Medications Production (2019-2030) & (K Units)
    Figure 5. World Hyperthyroidism Medications Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Hyperthyroidism Medications Production Value Market Share by Region (2019-2030)
    Figure 7. World Hyperthyroidism Medications Production Market Share by Region (2019-2030)
    Figure 8. North America Hyperthyroidism Medications Production (2019-2030) & (K Units)
    Figure 9. Europe Hyperthyroidism Medications Production (2019-2030) & (K Units)
    Figure 10. China Hyperthyroidism Medications Production (2019-2030) & (K Units)
    Figure 11. Japan Hyperthyroidism Medications Production (2019-2030) & (K Units)
    Figure 12. Hyperthyroidism Medications Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 15. World Hyperthyroidism Medications Consumption Market Share by Region (2019-2030)
    Figure 16. United States Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 17. China Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 18. Europe Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 19. Japan Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 22. India Hyperthyroidism Medications Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Hyperthyroidism Medications by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Hyperthyroidism Medications Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Hyperthyroidism Medications Markets in 2023
    Figure 26. United States VS China: Hyperthyroidism Medications Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Hyperthyroidism Medications Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Hyperthyroidism Medications Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Hyperthyroidism Medications Production Market Share 2023
    Figure 30. China Based Manufacturers Hyperthyroidism Medications Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Hyperthyroidism Medications Production Market Share 2023
    Figure 32. World Hyperthyroidism Medications Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Hyperthyroidism Medications Production Value Market Share by Type in 2023
    Figure 34. Methimazole
    Figure 35. Propylthiouracil
    Figure 36. Other
    Figure 37. World Hyperthyroidism Medications Production Market Share by Type (2019-2030)
    Figure 38. World Hyperthyroidism Medications Production Value Market Share by Type (2019-2030)
    Figure 39. World Hyperthyroidism Medications Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Hyperthyroidism Medications Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Hyperthyroidism Medications Production Value Market Share by Application in 2023
    Figure 42. Hospital
    Figure 43. Clinic
    Figure 44. Other
    Figure 45. World Hyperthyroidism Medications Production Market Share by Application (2019-2030)
    Figure 46. World Hyperthyroidism Medications Production Value Market Share by Application (2019-2030)
    Figure 47. World Hyperthyroidism Medications Average Price by Application (2019-2030) & (US$/Unit)
    Figure 48. Hyperthyroidism Medications Industry Chain
    Figure 49. Hyperthyroidism Medications Procurement Model
    Figure 50. Hyperthyroidism Medications Sales Model
    Figure 51. Hyperthyroidism Medications Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Companies Mentioned

Merck
Herbrand PharmaChemicals
Shanghai Zhaohui Pharmaceutical
Beijing Yanjing Pharmaceutical
Jinghua Pharmaceutical Group
Guangzhou Kanghe Pharmaceutical
Zigong Honghe Pharmaceutical
Guangdong Huanan Pharmaceutical
Zibo Wankang Pharmaceutical Chemical
Qilu Pharmaceutical